CETP inhibitor Patent status


In addition to my previous post on CETP inhibitors, i here present patent status of some companies who involved in development of CETP inhibitor class of drugs.

The method of using CETP inhibitors for treating atherosclerosis and cardiovascular conditions, were known before 1993 .

The companies which are involved in development of CETP inhibitors are Japan Tabacco, Pfizer, Merck, Novartis, Bayer & Searle. Among these companies Merck has now presented positive outcome of Phase III results

Pfizer has many patent applications on combination of CETP inhibitors with other class of cardiovascular drugs like statins and Searle has some patent applications on combination of CETP inhibitors with Nicotinic acid, Fibric acid derivatives.

Torcetrapib’s product patent is WO 2000/017165; Anacetrapib’s product patent is US 7,652,049 and Dalcetrapib’s product patent is WO 1998/035937

A Complete list of Patents on CETP inhibitors is available here

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Drug developments & targets and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s